文献速递呼吸道感染

社区获得性肺炎住院患者按临床病程分类的发病率与死亡率

Incidence and Mortality of Adults Hospitalized With Community-Acquired Pneumonia According to Clinical Course.
PubMed 文献 · Chest · 2019-10-11

本研究为路易斯维尔肺炎研究的二次数据分析,共纳入7449例社区获得性肺炎(CAP)住院患者,按住院第一周客观标准分为临床改善、治疗失败和未缓解三组。结果显示77%患者达到临床改善,20%治疗失败,3%未缓解;治疗失败和未缓解者30天死亡率均为34%,1年死亡率分别为52%和51%。

要点

  • 住院CAP患者中77%达到临床改善,20%治疗失败,3%未缓解。
  • 治疗失败或未缓解者30天死亡率34%,1年死亡率约半数。
  • 临床改善者30天死亡率6%,1年死亡率23%。

核心结论

  • 超过75%的CAP住院患者可达到临床改善。
  • 临床失败或未缓解的CAP患者中,约每两人就有一人在住院后1年死亡。
  • 理解长期死亡率的发病机制对制定干预措施至关重要。

研究设计与样本

  • 本研究为路易斯维尔肺炎研究的二次数据分析。
  • 研究纳入研究期间因CAP住院的7449例患者。
  • 按住院第一周客观标准将临床病程分为改善、失败和未缓解三类。

主要发现

  • 30天死亡率:改善组6%,失败组34%,未缓解组34%。
  • 1年死亡率:改善组23%,失败组52%,未缓解组51%。

关键数值与推荐

  • 临床改善与治疗失败采用客观标准在住院第一周内判定。
  • 若改善与失败标准均未满足,则归类为未缓解。
  • P < .05视为具有统计学意义。

临床怎么用

  • 住院早期应依据客观标准识别治疗失败或未缓解的CAP患者。
  • 对治疗失败或未缓解患者需关注长期死亡风险,住院后1年内密切随访。

局限性

  • 本研究为二次数据分析,原文摘要未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: After hospitalization for community-acquired pneumonia (CAP), patients' clinical course may progress to clinical improvement, clinical failure, or nonresolving pneumonia. The epidemiology and outcomes of patients with CAP according to clinical course has not been well studied. The objective of this study was to characterize the incidence and outcomes for each clinical course of hospitalized patients with CAP. METHODS: This was a secondary data analysis of the University of Louisville Pneumonia Study. Clinical course was classified as improvement, failure, and nonresolving. Objective criteria were used to define improvement and failure during the first week of hospitalization. If neither group of criteria were met, the course was classified as nonresolving. Incidence for each clinical course was calculated. Mortality was evaluated at different time points through the first year. P < .05 was considered statistically significant. RESULTS: A total of 7,449 patients were hospitalized with CAP during the study period. Improvement was documented in 5,732 patients (77%), failure was documented in 1,458 patients (20%), and nonresolving CAP was documented in 259 patients (3%). Mortality at 30 days was 6% for those who improved, 34% for those who failed, and 34% for those with nonresolving pneumonia. Mortality at 1 year was 23%, 52%, and 51%, respectively. CONCLUSIONS: This study shows that > 75% of hospitalized patients with CAP will reach clinical improvement. One of two patients with clinical failure or nonresolving CAP may die 1 year after hospitalization. Understanding the pathogenesis of long-term mortality is critical to developing interventions.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Peyrani P, Arnold FW, Bordon J, et al. Incidence and Mortality of Adults Hospitalized With Community-Acquired Pneumonia According to Clinical Course. Chest. 2019. PMID: 31610158. doi:10.1016/j.chest.2019.09.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。